Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9NX57
UPID:
RAB20_HUMAN
Alternative names:
-
Alternative UPACC:
Q9NX57; Q5T9X5; Q9NX49
Background:
Ras-related protein Rab-20 is pivotal in cellular processes, including apical endocytosis/recycling, and the maturation and acidification of phagosomes that engulf pathogens like S.aureus and M.tuberculosis. It also facilitates the fusion of phagosomes with lysosomes, a critical step in the intracellular degradation of pathogens.
Therapeutic significance:
Understanding the role of Ras-related protein Rab-20 could open doors to potential therapeutic strategies, especially in enhancing the body's defense mechanisms against infectious diseases by targeting its function in phagosome maturation and acidification.